arrow
Back
N

Niels W.C.J. van de Donk

Department of Hematology

78H-index
625Paper Count
2.5WCitation Count
Published Papers 148
Publication Date
Clinical outcomes of newly diagnosed myeloma patients with SLIM criteria : a subgroup analysis of the CASSIOPEIA study
errLeukemia
IF13.4
err2026-08-13
err0
PREAI
errCyrille Touzeau; Aurore Perrot; Cyrille Hulin; Mammoun Dib; Gedeon Agbetsivi; Laure Vincent; Thierry Facon; Xavier Leleu; Niels W.C.J. van de Donk; Annemiek Broijl; Sonja Zweegman; Michel Delforge; Jill Corre; Pieter Sonneveld; Ariane Boumendil; Philippe Moreau
errShare
errSave
Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients
err2026-06-24
err0
errOAAI
errNiels W. C. J. van de Donk; Fredrik Schjesvold; Bronno van der Holt; Monique C. Minnema; Ka Lung Wu; Annemiek Broijl; Wilfried W. H. Roeloffzen; Alain Gadisseur; Giuseppe Pietrantuono; Ludek Pour; Vincent H. J. van der Velden; Thomas Lund; Massimo Offidani; Sara Bringhen; Luisa Giaccone; Wida Razawy; Paola Tacchetti; Katia Mancuso; Trine Silkjaer; Jo Caers; Sonja Zweegman; Roman Hájek; Reuben Benjamin; Annette Juul Vangsted; Mario Boccadoro; Francesca Gay; Pieter Sonneveld; Pellegrino Musto
errShare
errSave
Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspective
err2026-04-29
err0
errOAAI
errAL Alberto L. Horenstein; KA Kristine A. Frerichs; AC Angelo C. Faini; NW Niels W. C. J. van de Donk; FM Fabio Malavasi
errShare
errSave
Monocyte-mediated metabolic rewiring via CD31-CD38 interactions promotes growth and drug-resistance in multiple myeloma
err2026-04-16
err0
errOAAI
errRamin Raoof; Giada Dal Collo; Helga Simon-Molas; Panagiota Tzortzi; Konxhe Kulaj; Elif N. Demirez; Crescenzo Massaro; Renée Poels; Charlotte L. B. M. Korst; Chloe A. O'Neill; Wassilis S. C. Bruins; Marloes E. C. Broekmans; Payam Behradkia; Maria Krevvata; Sonja Zweegman; Arnon P. Kater; Serena R. Baglio; Tuna Mutis; Niels W. C. J. van de Donk
errShare
errSave
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial
err2026-04-06
err0
errOAAI
errFrancesca Gay; Wilfried Roeloffzen; Meletios A. Dimopoulos; Laura Rosiñol; Marjolein van der Klift; Roberto Mina; Albert Oriol; Eirini Katodritou; Ka Lung Wu; Paula Rodríguez Otero; Roman Hájek; Elisabetta Antonioli; Mark van Duin; Mattia D’Agostino; Joaquín Martínez-López; Elena M. van Leeuwen-Segarceanu; Elena Zamagni; Niels W. C. J. van de Donk; Katja C. Weisel; Luděk Pour; Jakub Radocha; Angelo Belotti; Fredrik Schjesvold; Joan Bladé; Hermann Einsele; Pieter Sonneveld; Mario Boccadoro; Annemiek Broijl
errShare
errSave
Immunoglobulin supplementation and longer dosing intervals reduce risk of infections in patients with RRMM treated with teclistamab
err2026-02-21
err0
errOAAI
errFebe Smits; Kaz Groen; Charlotte L. B. M. Korst; Kris A. Frerichs; Ilse Kuipers; Sandy Kruyswijk; Maaike E. M. de Ruijter; Kazem Nasserinejad; Sonja Zweegman; Niels W. C. J. van de Donk
errShare
errSave
Temporal trends in progression risk in smoldering myeloma: a systematic review
err2026-01-08
err0
errOAAI
errHeinz Ludwig; Efstathios Kastritis; Sarah Bernhard; Niels W.C.J. van de Donk; Mario Boccadoro; Evangelos Terpos; Pellegrino Musto; Pieter Sonneveld; Ghulam Rehman Mohyuddin
errShare
errSave
Uncovering the ultra-frail: A distinct subgroup in non-transplant eligible newly diagnosed patients with multiple myeloma, with an inferior clinical outcome
err2025-12-08
err0
errOAAI
errKazimierz Groen; Febe Smits; Kazem Nasserinejad; Mark-David Levin; Josien C. Regelink; Gert-Jan Timmers; Esther G. M. de Waal; Matthijs Westerman; Gerjo A. Velders; Koen de Heer; Rineke B. L. Leys; Roel J. W. van Kampen; Claudia A. M. Stege; Maarten R. Seefat; Inger S. Nijhof; Ellen van der Spek; Saskia K. Klein; Niels W. C. J. van de Donk; Paula F. Ypma; Sonja Zweegman
errShare
errSave
Comparative Efficacy of Talquetamab vs. Real-World Physician’s Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent
err2025-11-28
err0
errOAAI
errHermann Einsele; Philippe Moreau; Nizar Bahlis; Manisha Bhutani; Laure Vincent; Lionel Karlin; Aurore Perrot; Hartmut Goldschmidt; Niels W. C. J. van de Donk; Enrique M. Ocio; Joaquín Martínez López; Paula Rodríguez-Otero; Dominik Dytfeld; Andrzej Jakubowiak; Carolina Schinke; Britta Besemer; Sébastien Anguille; Salomon Manier; Leo Rasche; Raphael Teipel; Christof Scheid; Charlotte Pawlyn; Michele Cavo; Joris Diels; Francesca Ghilotti; Bonnie W. Lau; Thomas Renaud; Oleksiy Orel; Fenny Ong; Diogo F. Ramos; Eric Ammann; Trilok Parekh; Claire Albrecht; Katja Weisel; María-Victoria Mateos
errShare
errSave
Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4
err2025-11-26
err0
errOAAI
errPaula Rodríguez-Otero; Surbhi Sidana; Mathilde Kouwenhoven; Jordan M. Schecter; Nikoletta Lendvai; Kevin C. De Braganca; Ana Slaughter; Carolina Lonardi; Philip Vlummens; Helen Varsos; Christina Corsale; Deepu Madduri; Hao Zhao; Katherine Li; Erin Lee; Loreta Marquez; Man Zhao; Tzu-min Yeh; Diana Chen; Vicki Plaks; Rocio Montes de Oca; Erika Florendo; Nitin Patel; Muhammad Akram; Mythili Koneru; Bianca D. Santomasso; Jaime Gállego Perez-Larraya; Niels WCJ van de Donk
errShare
errSave
Sequencing BCMA- and GPRC5D-targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network
err2025-11-25
err0
errOAAI
errvan de Donk, Niels W. C. J.; Moreau, Philippe; San-Miguel, Jesus F.; Mateos, Maria-victoria; Dimopoulos, Meletios A.; Zweegman, Sonja; Gay, Francesca; Engelhardt, Monika; Mina, Roberto; Zamagni, Elena; Delforge, Michel; Beksac, Meral; Spencer, Andrew; Schjesvold, Fredrik; Driessen, Christoph; Kaiser, Martin; Perrot, Aurore; Wasch, Ralph; Korst, Charlotte L. B. M.; Broijl, Annemiek; Touzeau, Cyrille; Manier, Salomon; Hajek, Roman; Bila, Jelena; Seval, Guldane C.; O'dwyer, Michael; Ludwig, Heinz; Fernandez de Larrea, Carlos; Popat, Rakesh; Musto, Pellegrino; Rodriguez-Otero, Paula; Yong, Kwee; Kortum, Marin; Rasche, Leo; Terpos, Evangelos; Raab, Marc S.; Boccadoro, Mario; Sonneveld, Pieter; Einsele, Hermann
errShare
errSave
Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma
err2025-11-03
err0
errOAAI
errM. R. Seefat; D. G. J. Cucchi; L. van Boven; N. Durdu-Rayman; K. Groen; M.-D. Levin; K. de Heer; B. de Valk; R. Wester; E. van der Spek; R. Rentenaar; C. L. B. M. Korst; M. Quik; C. A. O'Neill; P. Tzortzi; F. Smits; R. Mathot; M. R. Heerma van Voss; N. W. C. J. van de Donk; T. Mutis; I. H. Bartelink; S. Zweegman
errShare
errSave
European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma
err2025-10-13
err0
errOAAI
errNiccolò Bolli; Mattia D'Agostino; Tina Bagratuni; Mario Boccadoro; Michele Cavo; Christoph Driessen; Hermann Einsele; Monika Engelhardt; Francesca Gay; Norma C. Gutiérrez; Roman Hájek; Toril Holien; Cristina João; Martin Kaiser; K. Martin Kortüm; Lisa Leypoldt; Philippe Moreau; Pellegrino Musto; Enrique M. Ocio; Marc S. Raab; Leo Rasche; Fredrik Schjesvold; Tereza Sevcikova; Evangelos Terpos; Cyrille Touzeau; Niels W. C. J. Van de Donk; Mark van Duin; Katja Weisel; Elena Zamagni; Tom Cupedo; Pieter Sonneveld; Carolina Terragna
errShare
errSave
Circulating tumor cells predict myeloma outcomes in daratumumab, bortezomib, lenalidomide, dexamethasone treated patients
errBlood
IF23.1
err2025-10-10
err0
errOAAI
errLuca Bertamini; Cathelijne Fokkema; Paula Rodriguez-Otero; Mark van Duin; Evangelos Terpos; Mattia D’Agostino; Vincent H.J. van der Velden; Niels W.C.J. van de Donk; Michel Delforge; Christoph Driessen; Roman Hajek; Hermann Einsele; Annette Vangsted; Diego Vieyra; Ricardo Attar; Anna Sitthi-Amorn; Robin Carson; Fredrik Schjesvold; Pawel Robak; Meral Beksac; Andrew Spencer; Annemiek Broijl; Tom Cupedo; Philippe Moreau; Mario Boccadoro; Pieter Sonneveld
errShare
errSave
Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN–HARMONY Alliance platform
err2025-10-09
err0
errOAAI
errAdrian Mosquera Orgueira; Marta Sonia Gonzalez Perez; Mattia D'Agostino; David A. Cairns; Alessandra Larocca; Juan José Lahuerta Palacios; Ruth Wester; Uta Bertsch; Anders Waage; Elena Zamagni; Carlos Pérez Míguez; Javier Alberto Rojas Martínez; Elias K. Mai; Davide Crucitti; Hans Salwender; Daniele Dall'Olio; Gastone Castellani; Manuel Piñeiro Fiel; Sara Bringhen; Sonja Zweegman; Michele Cavo; Sofía Iqbal; Jesus Maria Hernandez Rivas; Benedetto Bruno; Gordon Cook; Martin F. Kaiser; Hartmut Goldschmidt; Niels W. C. J. Van De Donk; Graham Jackson; Jesús F. San-Miguel; Mario Boccadoro; Maria-Victoria Mateos; Pieter Sonneveld
errShare
errSave
Immune signatures in older patients with newly diagnosed multiple myeloma are associated with survival outcomes of first-line therapy irrespective of frailty levels
err2025-10-05
err0
errOAAI
errWassilis S. C. Bruins; Febe Smits; Carolien Duetz; Kazem Nasserinejad; Kazimierz Groen; Charlotte L. B. M. Korst; A. Vera de Jonge; Rosa Rentenaar; Tamara Hageman; Meliha Cosovic; Merve Eken; Inoka Twickler; Paola M. Homan-Weert; Christie P. M. Verkleij; Kristine Frerichs; Mark-David Levin; Ellen van der Spek; Inger S. Nijhof; Roel van Kampen; Niels W. C. J. van de Donk; Sonja Zweegman; Tuna Mutis
errShare
errSave
Characterization and Management of Cytokine Release Syndrome From the MonumenTAL-1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma
err2025-10-02
err0
errOAAI
errNiels W. C. J. van de Donk; Ajai Chari; Thomas Martin; Amrita Krishnan; Leo Rasche; Jing Christine Ye; Rakesh Popat; Brea Lipe; Cesar Rodriguez; Carolina Schinke; Sheri Skerget; Deeksha Vishwamitra; Raluca Verona; Jue Gong; Indrajeet Singh; Michela Campagna; Tara Masterson; Brandi Hilder; Jaszianne Tolbert; Thomas Renaud; M. Damiette Smit; Christoph Heuck; Maria-Victoria Mateos
errShare
errSave
Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study
errBlood
IF23.1
err2025-09-24
err0
errOAAI
errAjai Chari; Niels W.C.J. van de Donk; Bhagirathbhai Dholaria; Katja Weisel; María-Victoria Mateos; Hartmut Goldschmidt; Thomas G. Martin; Daniel Morillo; Donna Reece; Paula Rodríguez-Otero; Manisha Bhutani; Anita D’Souza; Albert Oriol; Laura Rosiñol; Nizar J. Bahlis; Deeksha Vishwamitra; Sheri Skerget; Raluca I. Verona; Kalpana Bakshi; Lijuan Kang; Thomas J. Prior; Lien Vandenberk; Jaszianne Tolbert; Sangmin Lee; M. Damiette Smit; Ralph Wäsch
errShare
errSave
Circulating extracellular vesicle isomiR signatures predict therapy response in patients with multiple myeloma
err2025-09-16
err0
errOAAI
errCristina Gómez-Martín; Esther E.E. Drees; Monique A.J. van Eijndhoven; Nils J. Groenewegen; Steven Wang; Sandra A.W.M. Verkuijlen; Jan R.T. van Weering; Ernesto Aparicio-Puerta; Leontien Bosch; Kris A. Frerichs; Christie P.M. Verkleij; Marie J. Kersten; Josée M. Zijlstra; Daphne de Jong; Catharina G.M. Groothuis-Oudshoorn; Michael Hackenberg; Johan R. de Rooij; Niels W.C.J. van de Donk; D. Michiel Pegtel
errShare
errSave
European Myeloma Network Consensus Statement on Functional High-Risk Multiple Myeloma
err2025-09-09
err0
PREAI
errSueh-li Lim; Monika Engelhardt; Evangelos Terpos; Francesca Gay; Niels W. C. J. Van de Donk; Herman Einsele; Pieter Sonneveld; Martin Kaiser; Mario Boccadoro; Andrew Spencer
errShare
errSave